SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-12-024434
Filing Date
2012-05-10
Accepted
2012-05-10 16:58:28
Documents
8
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 3-31-2012 form10q.htm 10-Q 455030
2 EXHIBIT 31 ex31.htm EX-31.1 18617
3 EXHIBIT 32 ex32.htm EX-32.2 8738
  Complete submission text file 0001140361-12-024434.txt   1705847

Data Files

Seq Description Document Type Size
4 INSTANCE DOCUMENT bstc-20120331.xml EX-101.INS 155125
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bstc-20120331.xsd EX-101.SCH 11924
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bstc-20120331_cal.xml EX-101.CAL 30262
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bstc-20120331_lab.xml EX-101.LAB 134400
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bstc-20120331_pre.xml EX-101.PRE 77894
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 12831080
SIC: 2834 Pharmaceutical Preparations